0001209191-16-109755.txt : 20160321
0001209191-16-109755.hdr.sgml : 20160321
20160321162255
ACCESSION NUMBER: 0001209191-16-109755
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160317
FILED AS OF DATE: 20160321
DATE AS OF CHANGE: 20160321
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBEIMMUNE INC
CENTRAL INDEX KEY: 0001245104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841353925
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1450 INFINITE DRIVE
CITY: LOUISVILLE
STATE: CO
ZIP: 80027
BUSINESS PHONE: 3036252744
MAIL ADDRESS:
STREET 1: 1450 INFINITE DRIVE
CITY: LOUISVILLE
STATE: CO
ZIP: 80027
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Torres S. Edward
CENTRAL INDEX KEY: 0001552293
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35642
FILM NUMBER: 161518945
MAIL ADDRESS:
STREET 1: C/O LILLY VENTURES FUND I LLC
STREET 2: 115 W. WASHINGTON ST, STE 1680 SOUTH
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46204
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-03-17
0
0001245104
GLOBEIMMUNE INC
GBIM
0001552293
Torres S. Edward
C/O LILLY VENTURES FUND I, LLC
115 W. WASHINGTON ST., S TOWER, STE 1680
INDIANAPOLIS
IN
46204
1
0
0
0
Common Stock
2016-03-17
4
S
0
26188
1.6663
D
241706
I
By Lilly Ventures Fund I, LLC
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.60 to $1.84 per share, inclusive. The reporting person undertakes to provide to GlobeImmune, Inc., any security holder of GlobeImmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
These shares are owned directly by Lilly Ventures Fund I, LLC (the "Fund"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein.
/s/ Brent D. Fassett, Attorney-in-Fact for S. Edward Torres
2016-03-21